Win 2 = profit from treating respiratory problems
Tobacco giant Philip Morris raises bid for respiratory drugmaker: Tobacco giant Philip Morris has raised its bid to buy respiratory drugmaker Vectura to more than £1bn.
Vectura makes inhaled medicines and devices to treat respiratory illnesses such as asthma, and counts Novartis and GSK among its customers.
Tobacco giant Philip Morris raises bid for respiratory drugmaker: Tobacco giant Philip Morris has raised its bid to buy respiratory drugmaker Vectura to more than £1bn.
Vectura makes inhaled medicines and devices to treat respiratory illnesses such as asthma, and counts Novartis and GSK among its customers.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.